Aspen Pharmacare reported ZAR12.34B in Cash and Equivalent for its fiscal semester ending in June of 2024.


Cash And Equivalent Change Date
Adcock Ingram Holdings ZAR 79.14M 10.28M Dec/2024
Aspen Pharmacare ZAR 12.34B 739M Jun/2024
Cipla INR 8B 1.22B Mar/2025
Dr.Reddys Laboratories INR 9B 5.65B Jun/2025
Jiangsu Hengrui CNY 36.12B 12.04B Jun/2025
Kalbe Farma IDR 3.8T 715.05B Jun/2025
Life Healthcare ZAR 2.46B 7.69B Sep/2024
Netcare ZAR 1.8B 201M Sep/2024
Richter Gedeon HUF 135.63B 61.59B Dec/2024